Aster Capital Management DIFC Ltd Takes $859,000 Position in Colgate-Palmolive Company $CL

Aster Capital Management DIFC Ltd bought a new position in Colgate-Palmolive Company (NYSE:CL) in the third quarter, according to its most recent filing with the SEC. The firm bought 10,747 shares of the company’s stock, valued at approximately $859,000.

A number of other hedge funds have also bought and sold shares of CL. Westside Investment Management Inc. lifted its stake in shares of Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after buying an additional 130 shares during the period. Copia Wealth Management acquired a new stake in Colgate-Palmolive during the 3rd quarter worth about $29,000. Vermillion & White Wealth Management Group LLC grew its stake in Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after purchasing an additional 155 shares during the last quarter. Cloud Capital Management LLC acquired a new position in shares of Colgate-Palmolive in the third quarter valued at about $30,000. Finally, MTM Investment Management LLC purchased a new position in shares of Colgate-Palmolive in the second quarter worth about $39,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $97.50 on Friday. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.27 and a current ratio of 0.83. The firm has a fifty day moving average of $87.08 and a 200 day moving average of $82.63. The firm has a market cap of $78.59 billion, a PE ratio of 37.21, a PEG ratio of 4.36 and a beta of 0.29. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the business earned $0.91 earnings per share. As a group, research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were paid a $0.52 dividend. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.1%. Colgate-Palmolive’s payout ratio is currently 79.39%.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent research reports. TD Cowen reiterated a “buy” rating on shares of Colgate-Palmolive in a research report on Monday, February 2nd. Wells Fargo & Company lifted their price objective on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a research note on Sunday, February 1st. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price for the company in a research report on Tuesday, December 9th. Finally, Piper Sandler increased their price target on Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research report on Friday, January 30th. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $94.75.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the firm’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the transaction, the insider owned 17,645 shares in the company, valued at approximately $1,663,041.25. This trade represents a 54.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Panagiotis Tsourapas sold 15,000 shares of the company’s stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at $1,018,691.15. The trade was a 59.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 184,683 shares of company stock valued at $17,486,693 over the last ninety days. Company insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.